Aimei Health Technology (AFJK) Return on Capital Employed (2024 - 2025)

Aimei Health Technology (AFJK) posted quarterly Return on Capital Employed of 2.34% for Q3 2025, up 7.43% quarter-over-quarter from 2.52% in Q2 2025.

Aimei Health Technology (AFJK) Return on Capital Employed (2024 - 2025) Analysis & Trends

Aimei Health Technology (AFJK) has reported Return on Capital Employed for 2 consecutive years, with 2.34% the latest figure, recorded in Q3 2025.

In Q3 2025, Return on Capital Employed changed N/A year-over-year to 2.34%; the TTM figure through Sep 2025 stood at 2.34% (changed N/A YoY), while the FY2024 annual figure was 1.49%, changed N/A from the prior year.
Return on Capital Employed improved to 2.34% in Q3 2025 per AFJK's latest filing, from 2.52% in the prior quarter.
Across five years, Return on Capital Employed topped out at 1.47% in Q4 2024 and bottomed at 2.52% in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROCE (Qtr)
1	Oxley Bridge Acquisition	585.76 Mn	585.76 Mn	-	-0.24%
2	Launch Two Acquisition	557.86 Mn	557.86 Mn	-	-0.37%
3	Drugs Made In America Acquisition	507.00 Mn	507.00 Mn	-	-
4	Cantor Equity Partners IV	468.00 Mn	468.00 Mn	-	-
5	GP-Act III Acquisition	401.06 Mn	401.06 Mn	-	-0.90%
6	Aldel Financial	397.49 Mn	397.49 Mn	-	-0.29%
7	Republic Digital Acquisition	389.25 Mn	388.51 Mn	-	-0.14%
8	Gores Holdings X	385.06 Mn	384.87 Mn	-	-0.86%
9	Agriculture & Natural Solutions Acquisition	377.29 Mn	377.04 Mn	-	-
10	Aimei Health Technology	50.90 Mn	50.89 Mn	-	-

Download Data